ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

13.56

-0.18 (-1.32%)

Jul 15, 2026, 4:00 PM EDT - Market closed

-1.32% (1D)

Assets	$2.53M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	165,519
Dividend (ttm)	$0.79
Dividend Yield	5.81%
Ex-Dividend Date	Jun 24, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	3,970
Open	13.80
Previous Close	13.74
Day's Range	13.55 - 13.80
52-Week Low	12.37
52-Week High	33.13
Beta	-1.17
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange NASDAQ

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-200.78% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-27.51%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-36.03%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-39.31%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-46.51%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-51.42%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 24, 2026	$0.1366	Jun 30, 2026
Mar 25, 2026	$0.13714	Mar 31, 2026
Dec 24, 2025	$0.20514	Dec 31, 2025
Sep 24, 2025	$0.30854	Sep 30, 2025
Jun 25, 2025	$0.2161	Jul 1, 2025
Mar 26, 2025	$0.2651	Apr 1, 2025

Full Dividend History

Performance

BIS had a total return of -55.55% in the past year, including dividends. Since the fund's inception, the average annual return has been -32.69%.